Citation
82 FR 42101
Multiple canonical documents share this first-page citation.
- Design Considerations and Premarket Submission Recommendations for Interoperable Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability Wednesday, September 6, 2017 82 FR 42101
- Determination That GYNOREST (Dydrogesterone) Oral Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness Wednesday, September 6, 2017 82 FR 42101